Washington; A woman's right to choose

WASHINGTON - FDA last week proposed a rule intended to ensure that neither women nor men are excluded from clinical studies of drugs and biologics to treat life-threatening diseases simply because they are able to procreate or for fear of potential fetal exposure.

The proposed rule would allow FDA to issue a clinical hold on any proposed or ongoing clinical trial for a life-threatening disease "if men or women with reproductive potential who have the disease being studied are excluded from eligibility in any phase of clinical investigation because of a risk or potential

Read the full 930 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers